Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
26-Apr-16 The Japanese government will work with medical device maker Nihon Trim to set up a chain of hospitals in China, to promote medical exports while helping to alleviate the shortage of facilities there for treating lifestyle diseases. Mitsubishi Corp and other major companies are considering contributing through such steps as developing meals for diets designed to prevent diabetes. [image: Reuters]
Read More
25-Apr-16 Singapore's leading private medical provider, Raffles Medical Group, is seeking opportunities to open hospitals and medical centers in China's top cities. The group plans to open a 400-bed facility in Shanghai in 2018, adding to existing clinics in seven cities in China, including Shanghai, Beijing, Nanjing and Dalian. [image: Nikkei Asian Review]
Read More
24-Apr-16 Australia's third largest private healthcare group, Healthe Care, officially became a member of Luye Medicals Group Pte Ltd (Luye Medical Group) after the acquisition from Australia's Archer Capital Fund was completed. Through this acquisition, Luye Medical has leapfrogged into the ranks of the largest international private medical groups in the region. [image: Luye Medical Group]
Read More
22-Apr-16 Medical imaging company Carestream Health will build a cloud platform to establish a new clinical ecosystem in China. The company is discussing the project with several large hospitals and IT companies including Alibaba, with whom Carestream has already announced a partnership. The aim is gradually to provide complete medical IT solutions via the platform. [image: Carestream Health]
Read More
21-Apr-16 The Indonesian government has decided to develop its own vaccine with state-owned company PT Bio Farma. The Health Ministry said it would not use the vaccine issued by Sanofi because it did not match with the types of dengue commonly found in Indonesia. [image: Break Dengue]
Read MoreGGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in Asia, Latam, the Middle East & Africa, Europe and North America.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Find out more about our international market intelligence and strategy services
Get in touch to discuss your growth markets research and advisory needs:
Email: info@ggmkts.com
Follow us: